Loading market dashboard
Carter Bankshares, Inc.
CAREFinancial ServicesNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Located in the Daniel Building, the Loan Production Office will house the Bank's Commercial Banking team. GREENVILLE, SC / ACCESS Newswire / June 2, 2026 / Carter Bank (Nasdaq:CARE) announced today the opening of a Loan Production Office in Greenville, marking the bank's first physical location in the Palmetto State.
Carter Bankshares (CARE) executed a transformative sale of non-performing loans, realizing a $65M gain and boosting tangible book value to $22.69 per share. CARE's Q1 reported EPS of $3.88 is inflated by non-recurring items; underlying earnings are closer to $0.40 per share. With $228M+ in cash post-sale, CARE is positioned to redeploy capital into higher-yielding assets, likely driving net interest income growth in Q2 and Q3.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
(CSE: URAI / OTC: URAIF / FSE: 3QG0) investor@inturai.com Highlights Inturai completed an Australian product tour and delivered its Duo devices to a large aged care group and a retail technology company, spanning movement and occupancy tracking, human presence detection, falls monitoring, sleep, heart rate and breathing analysis. The deployments, including a live demo home in Brisbane, validate the Company's AI-native, hardware-light platform across two distinct market verticals, demonstrating operational readiness and advancing Inturai's commercial strategy.
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ:OPCH). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 24, 2026, Option Care Health announced fourth quarter 2025 earnings. On.
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced that its CARE Program (Comprehensive, Assessment, Risk, and Education) has been awarded “Best Overall Health Informatics Solution” in the 10th Annual MedTech Breakthrough Awards. The global program recognizes excellence in digital health and medical technology, selecting CARE from more than 5,000 nominations worldwide. The CA.
MARTINSVILLE, Va.--(BUSINESS WIRE)--Carter Bank (Nasdaq: CARE) today announced the launch of two new products, carter youth savings and carter youth checking, designed to help children and teens develop smart money habits and build a strong financial foundation. Available to youth from ages 6 up to 18 years old, these accounts give parents and guardians a hands-on role in guiding and monitoring their child's spending and saving habits. Once the account holder turns 18, the youth checking accoun.
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming European Wound Management Association (EWMA) Conference, Bremen between 6-8 May 2026.
Does Carter Bankshares, Inc. (CARE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Shares of Carter Bankshares, Inc. (NASDAQ: CARE - Get Free Report) have received an average rating of "Buy" from the five research firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to
Carter Bankshares, Inc. (CARE) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $3.91 per share. This compares to earnings of $0.32 per share a year ago.
MARTINSVILLE, VA / ACCESS Newswire / April 23, 2026 / The board of directors of Carter Bankshares, Inc. (the "Company") (NASDAQ:CARE), the holding company of Carter Bank (the "Bank"), approved a cash dividend of $0.10 per share on April 22, 2026. Based on the closing stock price on April 21, 2026 of $24.44, the annualized dividend yield is 1.64%.
MARTINSVILLE, VA / ACCESS Newswire / April 23, 2026 / Carter Bankshares, Inc. (the "Company") (NASDAQ:CARE), the holding company of Carter Bank (the "Bank") today announced quarterly net income of $85.8 million, or $3.88 diluted earnings per share ("EPS"), for the first quarter of 2026 compared to net income of $8.5 million, or $0.38 diluted EPS, for the fourth quarter of 2025 and net income of $9.0 million, or $0.39 diluted EPS, for the first quarter of 2025. Net interest income was $35.9 million for the first quarter of 2026, $34.6 million for the fourth quarter of 2025, and $30.1 million for the first quarter of 2025.
Carter Bankshares (CARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jeffersonville Bancorp (OTCMKTS:JFBC - Get Free Report) and Carter Bankshares (NASDAQ: CARE - Get Free Report) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, risk, profitability, analyst recommendations, valuation, earnings and dividends. Valuation and Earnings This table compares Jeffersonville
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance backed by a portfolio of strong scientific data and clinical evidence.
